Little Green Pharma takes home two awards at the annual Cannabiz Awards, taking home the award for Best Patient-Focused Initiative and R&D Project of the Year.
Held in June in Melbourne, the Cannabiz Awards aim to highlight the success stories within the industry.
We’re honoured to be recognised for our exceptional achievements related to our successful QUEST Study held with the University of Sydney and the work LGP does in assisting patients access medical cannabis.
At Little Green Pharma, the patient really is at the centre of everything we do. Our commitment to ease of patient access has been in place since Little Green Pharma launched its first medication in 2018 and has helped vulnerable Australians access medication that they would otherwise not be able to.
In 2022, we also introduced a 10% discount for Concession Card and Healthcare Card Holders on all our medications upon presentation of a valid concession card at the dispensing pharmacy.
This double victory serves as a testament to the tireless efforts of our team, whose passion and expertise have been instrumental in driving our success. We are immensely proud of their unwavering commitment and congratulate them on this outstanding achievement!
As we celebrate these remarkable wins, we remain dedicated to delivering unparalleled quality, innovation, and support to our valued stakeholders. This recognition fuels our drive to revolutionise the industry.
Here’s to an even better 2024!
To read more about the Cannabiz Awards and see the full list of award recipients, visit Cannabiz Awards | Cannabiz